Baicalein.

Baicalein carries adjacent hydroxyl groups on its A ring that bind ferrous and ferric iron into stable complexes. Taken in the same dose, it can hold onto iron in the gut and lower how much of that iron is available for absorption, so spacing the two apart keeps iron intake predictable.

Baicalein is cleared quickly by intestinal and liver UDP-glucuronosyltransferases, so plasma levels of the free flavone stay low relative to the dose taken. Piperine inhibits those same conjugating enzymes, which is the standard formulation reason it is placed beside heavily glucuronidated polyphenols.

Baicalein is almost entirely glucuronidated in the gut wall by UGT1A9 and related enzymes, the same pathway quercetin saturates. Each slows the other's conjugation, leaving more free aglycone in circulation.

Luteolin and baicalein share the flavone scaffold, mast cell stabilising behaviour and the lipoxygenase pathway. Combining them broadens coverage at the same targets rather than raising one dose.

Both bind the benzodiazepine site of the GABA-A receptor as positive modulators with different subunit preferences. They are formulated together in evening blends for that reason.

Catechin regenerates the oxidised flavone radical and both quench the same reactive species in the aqueous phase. They also share methylation and glucuronidation clearance, so each extends the other's exposure.

Ascorbate donates an electron to the baicalein radical formed after it quenches oxidation, returning the flavone to its active form. This recycling is the standard basis for flavonoid plus ascorbate formulas.

Tocopherol handles radicals inside the membrane while baicalein works at the membrane surface and in the water phase. The two cover compartments neither reaches alone.

Baicalein drives Nrf2 translocation, which raises expression of glutamate cysteine ligase, the rate-limiting enzyme of glutathione synthesis. Supplying glutathione or its precursor covers the pool while that transcriptional step catches up.

Complexing a poorly soluble flavone with phosphatidylcholine is the established phytosome approach and it markedly raises the fraction absorbed. Baicalein's low aqueous solubility is its main absorption limit.

Baicalein's adjacent hydroxyl groups chelate divalent metals including zinc in the gut lumen, forming complexes the transporter does not take up. Where zinc status is the goal the doses belong apart.

The catechol-like hydroxyls on baicalein bind copper tightly, which quiets the metal's redox activity but also holds it away from absorption. The chelate is part of why the flavone reads as an antioxidant in tissue.

Curcumin and baicalein are both cleared mainly by intestinal glucuronidation, so each raises the other's exposure by competing for UGT capacity. Both also damp NF-kB driven signalling by separate routes.

Honokiol acts as a positive modulator at GABA-A through a site distinct from the flavone benzodiazepine pocket baicalein occupies. Two positions on one receptor is why they appear together in evening formulas.

Magnolia bark is the whole-plant source of honokiol and magnolol and has been paired with Scutellaria root in classical formulas for a very long time. The lignans and the flavones act on the same receptor from different sites.

Baicalein inhibits platelet 12-lipoxygenase and aggregation, and long chain omega-3s shift thromboxane balance the same direction. The two add up on normal clotting, which matters around procedures or with an anticoagulant.

Garlic organosulfur compounds reduce platelet aggregation through a separate route to flavone lipoxygenase inhibition. Combined, the effect on normal clotting is larger than from either alone.

Baicalin is the 7-O-glucuronide of baicalein and is the form that dominates Scutellaria baicalensis root. Gut bacterial beta-glucuronidase removes the sugar so that baicalein is the species actually absorbed, and absorbed baicalein is then re-conjugated back to baicalin in the intestinal wall and liver. The two are a single interconverting pair rather than two independent ingredients, which is why an individual's microbial population changes what reaches circulation.

Wogonin sits beside baicalein and baicalin in Scutellaria baicalensis root and shares the flavone scaffold and much of the same phase II handling. Because both compete for the same UDP-glucuronosyltransferase capacity, a whole-root extract behaves differently from isolated baicalein. Wogonin also appears in the co-study index for baicalein, so the pairing reflects how the literature actually studies them.

Sulforaphane modifies cysteine residues on Keap1 and is one of the most characterised Nrf2 activators in the diet. Baicalein has been reported to act on the same Nrf2 axis in cell work. Because the target is shared, the effect may overlap rather than simply add, and the evidence for the pair is cell-based rather than clinical.

Alpha-lipoic acid cycles between oxidised and dithiol forms and participates in regenerating other reduced antioxidants. Baicalein, as a catechol-type flavone, is itself oxidised as it quenches radicals. Cycling chemistry of this sort is well described in principle, though the specific pairing rests on mechanism rather than trial data.

Every glutathione peroxidase isoform carries a selenocysteine residue in its active site, so peroxide disposal capacity is limited by selenium status. Flavone-driven upregulation of antioxidant enzymes has nothing to act with if that mineral is short. This is settled nutritional biochemistry rather than a claim about the pair.

Ubiquinol is the main lipid-phase antioxidant of the inner mitochondrial membrane and also regenerates oxidised tocopherol. Baicalein partitions into membranes and chelates iron there, which is the setting where lipid peroxidation propagates. The two occupy the same compartment with different chemistry, so the rationale is mechanistic.

Astaxanthin spans the bilayer with its polar ends at both membrane surfaces, so it intercepts radicals inside the lipid phase. Baicalein sits nearer the membrane interface. Coverage of different depths of the same membrane is the mechanistic argument, and it has not been tested as a pair in people.

Baicalein as a free aglycone is markedly less water soluble than its glucuronide, which is one reason oral levels are low and variable. Medium-chain lipid vehicles disperse such compounds and prompt bile release. This is formulation chemistry; no comparison of vehicles in people is cited here.

Phospholipid complexation is the standard route used to make poorly soluble flavonoids disperse in the gut, and it is why phospholipid-flavonoid complexes exist as commercial ingredients. Baicalein is a candidate for the same treatment because of its low aqueous solubility. The claim here is about dispersion, not about a clinical result.

Silymarin flavonolignans are heavily glucuronidated and inhibit several UGT isoforms in vitro. Baicalein is cleared by the same conjugation route. Taken together, each can slow the other's clearance, which raises exposure in a way that is not necessarily predictable and matters most for anyone also taking a glucuronidated medicine.

Pterostilbene is the dimethyl ether of resveratrol and is conjugated more slowly than its parent, so it persists longer. Pairing a slowly cleared stilbene with a rapidly conjugated flavone is a formulation argument about differing time courses. The pairing has not been studied together and the confidence is early.